Vertex Pharmaceuticals

Yahoo Finance • 13 hours ago

4 Healthcare Stocks to Buy Now

Key Points Two gene-editing companies are advancing therapies, with one generating commercial sales and both approaching major regulatory milestones. An AI drug discovery company is approaching multiple trial readouts in late 2025 that co... Full story

Yahoo Finance • 3 days ago

Is Vertex Stock Poised for Growth After Positive CRISPR Therapy Trial Results in 2025?

If you're holding shares of Vertex Pharmaceuticals or thinking about adding some to your portfolio, you're not alone in wondering what the right move is. The stock's recent momentum may have caught your eye. Over just the past week, Vertex... Full story

Yahoo Finance • 7 days ago

What Makes Vertex Pharmaceuticals (VRTX) an Investment Bet?

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equities continued their upward journey in the... Full story

Yahoo Finance • 9 days ago

Here's Why Vertiv Stock Soared This Week

Key Points The announcement of another strategic partnership in the data center space confirms that spending on AI and data centers is much more than a passing trend. Vertiv's data center infrastructure solutions make it ideally placed to... Full story

Yahoo Finance • 13 days ago

Healthy Aging Summit Highlights Urgent Need for Safer Pain Management Among Older New Jerseyans

Atlantic City, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The first-ever NJ Healthy Aging Summit, convened by the Partnership for a Drug-Free New Jersey (PDFNJ) in partnership with the New Jersey Division of Mental Health and Addiction Services... Full story

Yahoo Finance • 15 days ago

5 Top Stocks to Buy in October

With the first three quarters of the calendar year in the books, investors are strolling into October with the major indexes at all-time highs and a more than 20% year-to-date gain in the S&P 500 and Nasdaq Composite. Go back even further,... Full story

Yahoo Finance • 16 days ago

What Vertex Pharmaceuticals (VRTX)'s FDA Breakthrough for Povetacicept Means for Kidney Disease Pipeline

Vertex Pharmaceuticals recently announced that the FDA has granted Breakthrough Therapy Designation to povetacicept for IgA nephropathy, along with key clinical advancements in its kidney disease pipeline. This regulatory milestone may hel... Full story

Yahoo Finance • 16 days ago

VRTX Quantitative Stock Analysis

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INCORPORATED (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our Twin Momentum Investor model based on the published strategy of Dashan Huang. Thi... Full story

Yahoo Finance • 17 days ago

Guru Fundamental Report for VRTX

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth... Full story

Yahoo Finance • 19 days ago

Why Vertiv (VRT) Shares Are Trading Lower Today

What Happened? Shares of data center products and services company Vertiv (NYSE:VRT) fell 6.2% in the afternoon session after Microsoft announced it had successfully tested a new microfluidic cooling system for data center chips, posing a... Full story

Yahoo Finance • 19 days ago

Vertiv stock falls after Microsoft unveils advanced chip cooling system

Investing.com -- Vertiv Holdings Co. (NYSE: VRT) shares fell 7% Tuesday after Microsoft (NASDAQ: MSFT) announced the successful testing of a new microfluidic cooling system for data center chips that could potentially disrupt the thermal m... Full story

Yahoo Finance • 23 days ago

Healthcare Stocks Are at an Historic Low and a Turnaround Is on the Horizon

Key Points It is a good time to invest in healthcare stocks. Investors should look into Pfizer and Vertex Pharmaceuticals. Pfizer's financial results and pipeline have improved, which should allow it to overcome upcoming headwinds. Vertex... Full story

Yahoo Finance • 25 days ago

CRISPR Therapeutics wins new Overweight rating at J.P. Morgan on pipeline prospects

[Business on Wall Street in Manhattan] Pgiam/iStock via Getty Images CRISPR Therapeutics (NASDAQ:CRSP [https://seekingalpha.com/symbol/CRSP]) traded higher in the premarket on Thursday after J.P. Morgan initiated its coverage with an Over... Full story

Yahoo Finance • 27 days ago

Alger Russell Innovation Index Updates for Third Quarter 2025

NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Fred Alger Management, LLC ("Alger"), a privately held growth equity investment manager, today announced the quarterly rebalancing of the Alger Russell Innovation Index ("Index"). Following the clos... Full story

Yahoo Finance • 28 days ago

Validea Detailed Fundamental Analysis - VRTX

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INCORPORATED (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our Twin Momentum Investor model based on the published strategy of Dashan Huang. Thi... Full story

Yahoo Finance • 28 days ago

Vortex Energy Completes Ambient Noise Tomography (ANT) Field Program at Robinsons River Salt Project

VANCOUVER, British Columbia, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) is pleased to announce the successful completion of the field component of its Ambient No... Full story

Yahoo Finance • 28 days ago

What Is One of the Best Industrial Stocks to Buy Right Now?

Key Points The company's book-to-bill ratio suggests significant future growth. The AI/data center capital spending market may well be only in its early innings. 10 stocks we like better than Vertiv › It's no secret that the AI/data cent... Full story

Yahoo Finance • last month

Why Shares in This AI/Data Center Stock Surged This Week

Key Points A major new deal in the industry confirmed that the lights are all green for the data center infrastructure market. The company is preparing for another surge in growth in the coming years, with the introduction of new data cen... Full story

Yahoo Finance • last month

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Shows Strong Fundamentals and Technical Breakout Potential

VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX [https://www.chartmill.com/stock/quote/VRTX]) has appeared as a notable candidate from a screening method that mixes firm fundamental growth measures with encouraging technical breakout formations. T... Full story

Yahoo Finance • last month

US Cystic Fibrosis Therapeutics Market Forecast and Company Analysis Report 2025-2033 Featuring Vertex, Abbvie, Novartis, Gilead Sciences, Viatris, Pfizer, AstraZeneca, and F. Hoffmann-La Roche

Company Logo The United States Cystic Fibrosis Therapeutics Market is set to grow from an estimated US$ 2.32 billion in 2024 to US$ 4.72 billion by 2033, with an 8.22% CAGR from 2025 to 2033. This growth is driven by advancements in gene... Full story